Drug Type Small molecule drug |
Synonyms ICM |
Target |
Mechanism HMGB1 inhibitors(High Mobility Group Protein B1 inhibitors), HMGB2 inhibitors(high mobility group box 2 inhibitors), KEAP1 inhibitors(Kelch like ECH associated protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Preclinical | KR | 01 Jan 2024 | |
Parkinson Disease | Preclinical | KR | 01 Jan 2024 | |
Epilepsy | Preclinical | CN | 19 Apr 2023 | |
Epilepsy | Preclinical | KR | 19 Apr 2023 | |
Neuroinflammation | Preclinical | KR | 12 Oct 2014 |